DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $18,657 | -2.8% | 77,737 | +2.1% | 2.55% | -6.1% |
| Q1 2023 | $19,186 | -5.2% | 76,121 | -0.2% | 2.72% | -10.9% |
| Q4 2022 | $20,241 | -99.9% | 76,261 | -0.4% | 3.05% | -6.6% |
| Q3 2022 | $19,776,000 | +11.3% | 76,565 | +9.2% | 3.27% | +21.0% |
| Q2 2022 | $17,771,000 | -10.2% | 70,097 | +3.9% | 2.70% | +5.4% |
| Q1 2022 | $19,788,000 | -9.8% | 67,458 | +1.1% | 2.56% | +8.5% |
| Q4 2021 | $21,944,000 | +7.9% | 66,696 | -0.2% | 2.36% | +4.3% |
| Q3 2021 | $20,340,000 | +12.3% | 66,811 | -1.1% | 2.26% | +12.6% |
| Q2 2021 | $18,119,000 | +19.2% | 67,520 | -0.0% | 2.01% | +12.3% |
| Q1 2021 | $15,200,000 | +1.6% | 67,533 | +0.3% | 1.79% | -5.3% |
| Q4 2020 | $14,956,000 | +4.3% | 67,327 | +1.1% | 1.89% | -10.5% |
| Q3 2020 | $14,336,000 | +19.8% | 66,577 | -1.6% | 2.11% | +7.5% |
| Q2 2020 | $11,964,000 | +26.8% | 67,661 | -0.7% | 1.96% | +8.2% |
| Q1 2020 | $9,435,000 | -10.6% | 68,167 | -0.8% | 1.81% | +12.4% |
| Q4 2019 | $10,551,000 | -0.3% | 68,742 | -6.2% | 1.61% | -8.1% |
| Q3 2019 | $10,582,000 | -1.7% | 73,265 | -2.7% | 1.76% | +3.7% |
| Q2 2019 | $10,767,000 | +6.9% | 75,330 | -1.3% | 1.69% | +2.7% |
| Q1 2019 | $10,074,000 | +27.3% | 76,311 | -0.5% | 1.65% | +11.8% |
| Q4 2018 | $7,913,000 | -4.8% | 76,730 | +0.3% | 1.48% | +12.8% |
| Q3 2018 | $8,314,000 | +8.2% | 76,509 | -1.7% | 1.31% | +3.2% |
| Q2 2018 | $7,683,000 | -0.8% | 77,859 | -1.6% | 1.27% | -2.7% |
| Q1 2018 | $7,745,000 | +5.1% | 79,098 | -0.4% | 1.30% | +10.0% |
| Q4 2017 | $7,372,000 | +7.8% | 79,421 | -0.4% | 1.18% | +4.4% |
| Q3 2017 | $6,838,000 | -0.4% | 79,721 | -2.0% | 1.13% | -2.2% |
| Q2 2017 | $6,864,000 | +2.8% | 81,337 | +4.2% | 1.16% | +0.4% |
| Q1 2017 | $6,677,000 | +12.2% | 78,068 | +2.1% | 1.16% | +8.6% |
| Q4 2016 | $5,950,000 | -0.7% | 76,430 | -0.2% | 1.06% | -0.8% |
| Q3 2016 | $5,991,000 | -18.4% | 76,581 | +5.4% | 1.07% | -22.1% |
| Q2 2016 | $7,341,000 | +5.8% | 72,681 | -0.6% | 1.38% | +41.5% |
| Q1 2016 | $6,939,000 | +2.5% | 73,151 | +0.4% | 0.97% | -24.4% |
| Q4 2015 | $6,769,000 | +4.5% | 72,876 | +0.7% | 1.29% | +13.3% |
| Q3 2015 | $6,476,000 | +3.2% | 72,376 | -1.3% | 1.14% | +7.9% |
| Q2 2015 | $6,276,000 | -2.2% | 73,326 | -2.9% | 1.06% | -5.8% |
| Q1 2015 | $6,414,000 | +1.1% | 75,551 | +2.0% | 1.12% | -1.4% |
| Q4 2014 | $6,346,000 | +12.9% | 74,047 | +0.1% | 1.14% | +8.3% |
| Q3 2014 | $5,622,000 | +1.3% | 73,999 | +5.0% | 1.05% | +13.5% |
| Q2 2014 | $5,550,000 | +4.9% | 70,498 | -0.0% | 0.92% | -10.0% |
| Q1 2014 | $5,289,000 | -3.9% | 70,524 | -1.1% | 1.03% | -5.6% |
| Q4 2013 | $5,502,000 | +9.0% | 71,276 | -2.1% | 1.09% | +1.8% |
| Q3 2013 | $5,046,000 | +9.6% | 72,807 | +0.1% | 1.07% | +3.9% |
| Q2 2013 | $4,605,000 | – | 72,757 | – | 1.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |